Keep it real
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You mean like actually doing a clinical trial rather then just talk?
You right, it has been planned for years. Pity they never seem to make it to the execution phase.
All talk, no action Missling.
This sounds awefully similiar to what I’ve heard in January 2017 and here we are a year later with no movement...
Knowng all this, how the hell could Missling state as late as October that 3 trials would be initiated in 2017?
Don’t worry, the Good Doctor is looking after us.
Given that they already screwed up the timeline, I would assume that Anavex is eager to start Rett as soon as possible? We know Rett foundation is ready to help.
On Dec 11 Anavex announced they have submitted an IND for Rett trial. The FDA has 30 calendar days to review the IND. This period is now over and yet no trial has been announced...
The market sees it as it is: a lot of talk and no action.
I am sorry, which trial??
You mean those three that started in 2017??
We have endpoints but no trials...
If only they could start a trial to prove this hypotheses...
If that is the best PR Missling can put out then we are in for a ride.
Good doctor, yeah, ... more like crappy CEO
Yes there was a tweet saying dr Hoang had to cancel due personal circumstances.
Good effort, but i think TPIV is very much below anyone’s radar
So all a CEO needs to do is submit paperwork to the FDA and then the magical tooth-fairy gets trials up and running.
No wonder we are nowhere!
Isn't part of his job also to get trials up and running?
I know three of those that are 'running late'...
Like those three trials that started in 2017? Or the potential data readout in 2017?
Really, it is not rocket science. The exhibits are the same from the original S3 filing from 09/20/17.
Yawn... same old rehash from every other day.
That’s why it’s a good thing to take profit at every northbound turn.
Not too hard: sold a couple thousand trading shares I bought around 3 for 4. Eazy.
Nice illustration of what some volume can do. Now it’s gonna drip down again. Hope you took some profit!
Thanks for your continued contribution to thuis board!
Ten times normal volume... Whats up?
I am glad we are in agreement of what elements will constitute a proper future trial. However, haste is not an adjective I would attribute to AVXL. Consider that dr Missling PR'ed their collaboration with the FDA in designing a p2/3 back in November 2015, 25 months ago...
some interesting details to compare:
1) Independent Data Monitoring Committee
2) 856-patient Phase II clinical study
3) placebo-controlled
4) double-blind
and now for the bad part:
How about helping their shareholders? I thought Missling had retails best interest at heart. Guess not!
Mosts enlighting post. It feels good to know that TapImmune's interest are well looked after.
Cant be Hang ‘cause the stock would have been up again with his departure .
he thinks BIIB is still testing....
But we have Fadiran. He will call in favors at the FDA and our obstacles will magically disappear...
And if that does not work then Gottlieb is on our side, rewriting guidelines to be tailor made for Anavex.
I find myself agreeing with your conclusion. Pitty I did not concluded earlier. Ah well one day it will go back up again. Eventually a trial will start.
But just plain stupid to commit yourself to timings if you do not control it.